Identification of a critical interval for type 2 diabetes QTL on chromosome 4 in DDD-Ay mice
Mammalian Genome · 2025
DOI: 10.1007/s00335-025-10106-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mammalian Genome, 2025. Verfasst von Jun-Ichi Suto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Agrobiological Sciences, National Agriculture and Food Research Organization (NARO), Tsukuba, Ibaraki, 305-8634, Japan. jsuto@affrc.go.j…. Hauptthemen laut MEDLINE: Quantitative Trait Loci, Diabetes Mellitus, Type 2, Chromosomes, Mammalian. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Agrobiological Sciences, National Agriculture and Food Research Organization (NARO), Tsukuba, Ibaraki, 305-8634, Japan. jsuto@affrc.go.jp.
- Institute of Livestock and Grassland Science, National Agriculture and Food Research Organization (NARO), Tsukuba, Ibaraki, 305-0901, Japan.
- Laboratory of Environmental Hygiene, Department of Environmental Science, School of Life and Environmental Science, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa, 252-5201, Japan.
ORCID-Profile: Jun-Ichi Suto, Misaki Kojima
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Suto, J. I., & Kojima, M. (2025). Identification of a critical interval for type 2 diabetes QTL on chromosome 4 in DDD-Ay mice. Mammalian Genome. https://doi.org/10.1007/s00335-025-10106-2
Vancouver
Suto JI, Kojima M. Identification of a critical interval for type 2 diabetes QTL on chromosome 4 in DDD-Ay mice. Mammalian Genome. 2025. doi:10.1007/s00335-025-10106-2
BibTeX
@article{Suto2025,
author = {Suto, Jun-Ichi and Kojima, Misaki},
title = {Identification of a critical interval for type 2 diabetes QTL on chromosome 4 in DDD-Ay mice},
journal = {Mammalian Genome},
year = {2025},
doi = {10.1007/s00335-025-10106-2}
}
EUVIMED